跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,687 条关于
“TDP-43 proteinopathies”
全部
3,687
临床试验
2,080
药物
503
机构
123
资讯
981
10个月前
Robert Packard Center and ALS United Launch Joint Research Initiative to Target TDP-43 Pathways in ALS
11个月前
AC Immune Publishes First-in-Class TDP-43 PET Tracer Data in Nature Communications, Advances to Phase 1 Trial
6个月前
AC Immune Achieves First In Vivo Imaging of TDP-43 Brain Pathology with Novel PET Tracer ACI-19626
7个月前
Prothena Reports Q4 2025 Results as Neurodegeneration Pipeline Advances with Major Partnerships
去年
BRAVYL (Oral Fasudil) Shows Promise in Reducing TDP-43 Spread in ALS Patients
6个月前
AcuraStem Receives Target ALS Grant to Develop SYF2-Targeted Therapeutics for TDP-43 Dysfunction
3个月前
Systemic Gene Therapy SynCav1 Shields Brain from TDP-43 Damage by Fortifying Neuronal Resilience
9个月前
FDA Clears First-in-Class Vectorized Antibody Trial for ALS Targeting TDP-43 Pathology
10个月前
Voyager Therapeutics Advances Multi-Modal Neurotherapeutics Pipeline with Novel NeuroShuttle Platform and TDP-43 Collaboration
去年
Edaravone Shows Promise in Targeting TDP-43 Mislocalization in ALS, New Preclinical Research Reveals
第 1 页,共 99 页
上一页
下一页